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Chronic pulmonary paracoccidioidomycosis 
in an AIDS patient and Mycobacterium gordonae 
as confounding factor
Paracoccidioidomycosis is an endemic fungal 
infection restricted geographically to South 
and Central America. The incidence in patients 
with HIV/AIDS was 1.5%, higher than in the 
general population (0.02%). 
We report a case of a 47-year-old man pre-
sented with fi ve months of cough with yellow 
sputum, weight loss of 5 kg, daily evening fever, 
ranging from 38°C to 39°C, malaise, anorexia, 
dyspnea on exertion and night sweats. He re-
ported diagnosis of AIDS four years ago (initial 
CD4 = 86 cells/mm3). No previous opportun-
istic diseases and reported use of combination 
zidovudine-lamivudine and lopinavir boosted 
with ritonavir, both twice a day, during four 
years, but discontinued the use of drugs in the 
last six months on his own. During this period, 
his CD4 count decreased from 400 cells/mm3 to 
160 cells/mm3. He reported a history of 60 pack-
years smoking since the age of 15 years.
Physical examination was normal except for 
enlarged liver 3 cm from the costal margin in 
the midclavicular line, marked clubbed fi ngers 
and watch-glass nails. His arterial blood gases on 
room air was pH: 7.46; pO2: 131 mmHg; pCO2: 
29.8 mmHg; HCO3: 21.1 mEq/L; SO2: 99.1%; 
base excess (BE): -1.4 mmol/L; serum sodium, 
134 mEq/L; serum potassium, 3.7 mEq/L; lactate 
dehydrogenase (LDH), 340 IU/L; C-reactive pro-
tein (CRP), 11.8 mg/L; hemoglobin, 12.3 g/dL; Ht, 
38%; leukocytes, 2,810/mL; 1,600 neutrophils 
(55.9%); 800 lymphocytes (29.9%) and 300 
monocytes (11.4%). Platelets were 134.000/mL. 
Aspartate transaminase (AST) was 15 IU/L and 
alanine transaminase (ALT) was 11 IU/L. 
During hospitalization, antiretrovirals and 
primary prophylaxis for PCP with trimetho-
prim/sulfamethoxazole were reintroduced and 
the patient reported mild improvement of 
symptoms and resolution of fever.
Mycobacterium gordonae was isolated from 
sputum, tuberculin purifi ed protein derivative 
(PPD) intradermal test (RT23, 2 UI, 0,1 UmL) 
of zero millimeter and chest x-ray PA and lateral 
view presented superior and inferior left lobe and 
inferior right lobe cotton-like densities without 
air bronchogram, and classical “butterﬂ y wing” 
pattern. Chest computed tomography (CT) scan 
revealed bronchial diffuse wall thickening, con-
solidations and nodules with spiky irregular bor-
ders, with air bronchograms, measuring between 
0.6 and 4.7 cm in all lung lobes and areas of cen-
trilobular emphysema. 
A transparietal CT-guided biopsy of the 
nodule located in the posterior segment of 
left lower lobe revealed granulomatous in-
ﬂ ammatory reaction with large number of the 
characteristic “pilot wheel” of Paracoccidioides 
brasiliensis. Multiple budding yeasts (blastoco-
nidia) and demonstration by Grocott staining. 
Cultures in Sabouraud dextrose agar obtained 
from this material turned out negative. 
This case is a chronic adult form of paracoc-
cidioidomycosis, which accounts for 80-90% of 
cases and represents endogenous reactivation 
years after initial contact with the fungus. How-
ever, this is not the most frequent form in im-
munosupressed patient. Within the largest Bra-
zilian cohort of paracoccidioidomycosis (3,744 
patients) 53 (1.4%) patients were coinfected 
with HIV (Pbm-HIV), during 1986-2004.1 
Patients coinfected with HIV were younger (33.5 
± 8.9 years; range = 16-57 years), 42/53 smoked 
(79.2%) and were less involved in agricultur-
al occupations; 83.7% had CD4+ cell count 
< 200 cells/µL.1 As in the case presented, only 
15/53 of coinfected subjects were taking 
antiretroviral drugs, 10 of whom were taking 
trimethoprim-sulfamethoxazole for prophy-
laxis against Pneumocystis jiroveci infection.
Mycobacterium gordonae is found as a sap-
rophytic microorganism in sputum, gastric lav-
age and urine obtained from healthy hosts and 
is associated to hospital pseudo-outbreaks. It is 
the least pathogenic mycobacteria.2,3Diagnostic 
criteria of infection include fever for more 
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than two weeks, pulmonary infiltrates at chest radio-
graph and more than four respiratory samples positive 
for Mycobacterium gordonae with high colony counts of 
(> 100), histopathological confi rmation, evidence of dis-
semination (sepsis, infection of the cornea, peritoneum, 
urine and synovial ﬂ uid) and CD4 < 50 cells/µL.2 This case 
did not meet these criteria. 
In a case series clinical specimens obtained from 15 HIV-
negative patients with Mycobacterium gordonae ruled out the 
pathogenicity of this agent.4 Chest x-ray abnormality seen in 
nine patients was attributed to the underlying disease. Twelve 
of the 15 patients were followed-up for 12 months without 
recurrence of positive cultures. In another study of 21 HIV-
infected patients, 17 had progressed to AIDS, all presented 
fever for more than two weeks and 95.24% (20/21) had fe-
ver. Mean age was 39 years (range: 26-52), 11 were white; 
three blacks and seven Hispanics. Male/female ratio was 18:3, 
mean CD4 count was 56 cells/µL (ranging from 2 cells/µL to 
203 cells/µL). Two cases had disseminated disease.4 
We conclude that paracoccidiodomycosis, regardless of 
the form, must be considered in HIV-infected persons in 
countries where this mycosis is endemic.
[Braz J Infect Dis 2011;15(1):92-93]©Elsevier Editora Ltda.
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